Nitric oxide and peroxynitrite platelet levels in gestational hypertension and preeclampsia

Platelets

Volumn 23, Issue 1, 2012, Pages 26-35

  Mazzanti, Laura ^a   Raffaelli, Francesca ^a   Vignini, Arianna ^a   Nanetti, Laura ^a   Vitali, Paola ^a   Boscarato, Virginia ^a   Giannubilo, Stefano R ^a   Tranquilli, Andrea L ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Gestational hypertension; Nitric oxide; Peroxynitrite; Platelets; Preeclampsia

Indexed keywords

3 NITROTYROSINE; BETA ACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXYNITRITE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; MATERNAL HYPERTENSION; PARITY; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADULT; BLOOD PLATELETS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PEROXYNITROUS ACID; PRE-ECLAMPSIA; PREGNANCY;

EID: 83155164558     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.589543     Document Type: Article

References (75)

1. ACOG practice bulletin: Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. International Journal of Gynecology and Obstetrics 2002;77:67-75.
2. Llurba E, Gratacó s E, Martín-Gallán P, Cabero L, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radical Biology and Medicine 2004;37:557-570. (Pubitemid 38901088)
3. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, Farnot U, Bergsjø P, Bakketeig L, Lumbiganon P, et al. World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? American Journal of Obstetrics and Gynecology 2006;194(4):921-31.
4. Roberts JM, Redman CWG. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993;341: 1446-1450.
5. López-Jaramillo P, Arenas WD, García RG, Rincon MY, López M. The role of the L-arginine-nitric oxide pathway in preeclampsia. Therapeutic Advances in Cardiovascular Diseases 2008;2(4):261-75.
6. Escudero C, Sobrevia L. A hypothesis for preeclampsia: Adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 2008;29(6): 469-83.
7. Valera MC, Parant O, Vayssiere C, Arnal JF, Payrastre B. Physiologic and pathologic changes of platelets in pregnancy. Platelets 2010;21(8):587-95.
8. Ceyhan T, Beyan C, BaşerI, Kaptan K, Güngö r S, Ifran A. The effect of preeclampsia on complete blood count, platelet count and mean platelet volume. Annals of Hematology 2006;85:320-322. (Pubitemid 43732655)
9. Redman CW. Platelets and the beginnings of preeclampsia. New England Journal of Medicine 1990;323:478-480. (Pubitemid 20231562)
10. Nisell H, Grunewald C, Berglud M, Karlberg KE, Lunell NO, Sylven C. Platelet aggregation in vitro and ex vivo in normal pregnancy, pregnancy-induced hypertension, and preeclampsia. Hypertension and Pregnancy 1998;17:147-155. (Pubitemid 28383043)
11. Konijnenberg A, Stokkers EW, Van der Post JA, Schaap MC, Boer K, Bleker OP, Sturk A. Extensive platelet activation in preeclampsia compared with normal pregnancy: Enhanced expression of cell adhesion molecules. American Journal of Obstetrics and Gynecology 1997;176(2):461-469. (Pubitemid 27107940)
12. McCarthy AL, Woolfson RG, Raju SK, Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. American Journal of Obstetrics and Gynecology 1993;168:1323-1330. (Pubitemid 23122189)
13. Whigham KAE. Abnormal platelet function in preeclampsia. British Journal of Obstetrics and Gynecology 1978;85:28-32.
14. Hull AD, white CR, Pearce WJ. Endothelium-derived relaxing factor and cyclic GMP-dependent vasorelaxation in human chorionic plate arteries. Placenta 1994;15:363-75.
15. Gude NM. Endothelium-derived relaxing factor [NO] and the placenta. In: Rice GE and Breenecke SP, editors. Molecular aspect of placenta and fetal membranes autacoids. Boca, Raton, FL: CRC; 1993. pp 3-276.
16. Buttery LD, McCarthy A, Springall DR, Sullivan MH, Elder MG, Michel T, Polak JM. Endothelial nitric oxide synthase in the human placenta: Regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 1994;15:257-265. (Pubitemid 24132898)
17. Gude NM. Endothelium-derived relaxing factor (nitric oxide) and the placenta. In: Rice GE and Breenecke SP, editors. Molecular aspects of placenta and fetal membranes autacoids. Boca Raton, FL: CRC; 1993. pp 263-276.
18. Buttery LD, McCarthy A, Springall DR, Sullivan MH, Elder MG, Michel T, Polak JM. Endothelial nitric oxide synthase in the human placenta: Regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 1994;15:257-265. (Pubitemid 24132898)
19. Cameron IT, Van Papendorp CL, Palmer RMJ, Smith SK, Moncada S. Relation between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertension and Pregnancy 1993; 12:85-92. (Pubitemid 23191015)
20. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. American Journal of Obstetrics and Gynecology 1993;169:1316-20. (Pubitemid 24001657)
21. Cameron IT, Van Papendorp CL, Palmer RMJ, Smith SK, Moncada S. Relation between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertension and Pregnancy 1993; 12:85-92. (Pubitemid 23191015)
22. Moncada S, Martin JF, Higgs A. Symposium on regression of atherosclerosis. European Journal of Clinical Investigation 1993;23:385-398. (Pubitemid 23205451)
23. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New England Journal of Medicine 1993;30:2002-2010.
24. Naseem KM, Riba R. Unresolved roles of platelet nitric oxide synthase. Journal of Thrombosis and Haemostasis 2008; 6:10-19.
25. Radomski MW, Palmer RJ, Moncada S. An L-arginine to nitric oxide pathway in human platelets regulates aggregation. Proceedings of the National Academy of Sciences 1990; 87:5193-5197.
26. Mehta JL, Chen LY, Kone BC, Mehta P, Turner P. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. Journal of Laboratory and Clinical Medicine 1995;125(3):370-377.
27. Fleming I, Schulz C, Fichtlscherer B, Kemp BE, Fisslthaler B, Busse R. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets. Thrombosis and Haemostasis 2003;90: 863-871. (Pubitemid 37427856)
28. Marjanovic JA, Stojanovic A, Brovkovych VM, Skidgel RA, Du X. Signaling-mediated functional activation of inducible nitric-oxide synthase and its role in stimulating platelet activation. J Biol Chem. 2008 Oct 24;283(43):28827-34.
29. Chen LY, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. Journal of Cardiovascular Pharmocology 1996;27(1):154-158. (Pubitemid 26010653)
30. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-a and interferon-γ by mononuclear leukocytes in patients with ischemic heart disease relevance in superoxide anion generation. Circulation 1994;90:694-649.
31. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. American Journal of Cardiology 1990;65:297-302. (Pubitemid 20038909)
32. Szabo C. Multiple pathway of peroxynitrite cytotoxicity. Toxicology Letters 2003;140-141:105-112.
33. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as biomarker of peroxynitrite formation in vivo? FEBS Letters 1997;411:157-160. (Pubitemid 27301445)
34. Schiessl B, Strasburger CJ, Bidlingmaier M, Spannagl M, Ugele B, Kainer F. Decreasing resistance in the maternal uterine and peripheral arterial system is apparently unrelated to plasma and urinary levels of nitrite/nitrate and cyclic-guanosinmonophosohate during the course of normal pregnancies. Journal of Perinatal Medicine 2003;31: 281-286. (Pubitemid 36988195)
35. Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 1996; 28:488-493. (Pubitemid 26296056)
36. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. American Journal of Physiology 1996;271:1424-1437.
37. Kaaja RJ, Moore MP, Yandle TG, Ylikorkala O, Frampton CM, Nicholls MG. Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy. Hypertension and Pregnancy 1999;18:173-187. (Pubitemid 29323593)
38. Slowinski T, Neumayer HH, Stolze T, Gossing G, Halle H, Hocher B. Endothelin system in normal and hypertensive pregnancy. Clinical Science 2002;103:446S-449S. (Pubitemid 35007208)
39. Terán E, Escudero C, Vivero S, Enríquez A, Calle A. Intraplatelet cyclic guanosine-30,50-monophosphate levels during pregnancy and preeclampsia. Hypertension and Pregnancy 2004;23:303-308. (Pubitemid 39552303)
40. Vignini A, Nanetti L, Moroni C, Testa R, Sirolla C, Marra M, Cenerelli S, Gregori A, Fumelli D, Olivieri F, et al. Platelet nitric oxide production and IR: Relation with obesity and hypertriglyceridemia. Nutrition, Metabolism and Cardiovascular Diseases 2008;18:553-558.
41. Griess P. Bemerkungen zu Der Abhandlung Der HH. Weselsky und Benedikt Ueber einige Azoverbindungen. Berichte der Deutschen chemischen Gesellschaft. 1879;12(1):426428.
42. Sun J, Zhang X, Broderick M, Harry Fein. Measurement of nitric oxide production in biological systems by using Griess reaction assay. Sensors 2003;3(8):276-284. (Pubitemid 40643539)
43. Guevara I, Iwanejko J, Dembiń ska-Kieć A, Pankiewicz J, Wanat A, Anna P, Golabek I, Bartuś S, Malczewska- Malec M, Szczudlik A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clinica Chimica Acta 1998;274(2):177-88. (Pubitemid 28269300)
44. Weissman BA, Gross SS. Measurement of NO and NO synthase. Current Protocols in Neuroscience. 2001 Chapter 7:Unit7.13.
45. Moshage H, Kok B, Huizenga JR, Jansen PLM. Nitrite and nitrate determinations in plasma: A critical evaluation. Clinical Chemistry 1995;41/6:892-6.
46. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteine-dye binding. Analytical Biochemistry 1976;72:248-254.
47. Vignini A, Nanetti L, Moroni C, Tanase L, Bartolini M, Luzzi S, Provinciali L, Mazzanti L. Modifications of platelet from Alzheimer disease patients: A possible relation between membrane properties and NO metabolites. Neurobiology of Aging 2007;28:987-994. (Pubitemid 46635912)
48. Nanetti L, Giannubilo SR, Raffaelli F, Curzi CM, Vignini A, Moroni C, Tanase L, Carboni E, Turi A, Mazzanti L, et al. Nitric oxide and peroxynitrite platelet levels in women with small-for-gestational-age fetuses. BJOG 2008;115:14-21. (Pubitemid 350209619)
49. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. American Journal of Obstetrics and Gynecology 1994;171:944-948. (Pubitemid 24341474)
50. Mutlu-Turkoglu U, Aykac-Toker G, Ibrahimoglu L, Ademoglu E, Uysal M. Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecologic and Obstetric Investigation 1999;48:247-250.
51. Silver RK, Kupferminc MJ, Russell TL, Adler L, Mullen TA, Caplan MS. Evaluation of nitric oxide as a mediator of severe preeclampsia. American Journal of Obstetrics and Gynecology 1996;175:1013-1017. (Pubitemid 26357974)
52. Egerman RS, Andersen RN, Manejwala FM, Sibai BM. Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women. American Journal of Obstetrics and Gynecology 1999;181:921-923. (Pubitemid 29503616)
53. Smarason AK, Allman KG, Young D, Redman CW. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia. British Journal of Obstetrics and Gynecology 1997;104:538-543. (Pubitemid 27240417)
54. Bartha JL, Comino-Delgado R, Bedoya FJ, Barahona M, Lubian D, Garcia-Benasach F. Maternal serum nitric oxide levels associated with biochemical and clinical parameters in hypertension in pregnancy. European Journal of Obstetrics, Gynecology and Reproductive Biology 1999;82:201-207. (Pubitemid 29074320)
55. Pathak N, Sawhney H, Vasishta K, Majumdar S. Estimation of oxidative products of nitric oxide (nitrates, nitrites) in preeclampsia. The Australian and New Zealand Journal of Obstetrics and Gynecology 1999;39:484-487.
56. Shaamash AH, Elsnosy ED, Makhlouf AM, Zakhari MM, Ibrahim OA, EL-dien HM. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. International Journal of Gynaecology and Obstetrics 2000;68:207-214. (Pubitemid 30123009)
57. Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y, Fujita T, Kidoguchi KI, Azuma C, Saji F. Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecologic and Obstetric Investigation 1996;41:189-193. (Pubitemid 26137022)
58. Suzuki Y, Sawa S, Miura R, Doi A, Otsubo D, Araki Y, T. Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia. American Journal of Obstetrics and Gynecology 2002;187:676-680.
59. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. American Journal of Obstetrics and Gynecology 1996;174:1008-1013. (Pubitemid 26111684)
60. Conrad KP, Kerchner LJ, Mosher MD. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. American Journal of Physiology 1999;277:F48-F57. (Pubitemid 29352674)
61. Ranta V, Viinikka L, Halmesmaki E, Ylikorkala O. Nitric oxide production with preeclampsia. Obstetrics and Gynecology 1999;93:442-445. (Pubitemid 29107009)
62. Norris LA, Higgins JR, Darling MR, Walshe JJ, Bonnar J. Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstetrics and Gynecology 1999;93:958-963. (Pubitemid 29247103)
63. Baker PN, Davidge ST, Robets JM. Plasma from women with pre-eclampsia increases cell nitric oxide production. Hypertension 1995;26:244-248.
64. Konijnenberg A, Stokkers EW, Van der Post JA, Schaap MC, Boer K, Bleker OP, Sturk A. Extensive platelet activation in preeclampsia compared with normal pregnancy: Enhanced expression of cell adhesion molecules. American Journal of Obstetrics and Gynecology 1997;176:461-469. (Pubitemid 27107940)
65. Redmann CWG, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 2003;24:S21-S27. (Pubitemid 37184731)
66. Koo JR, Vaziri ND. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney International 2003;63:195-201. (Pubitemid 35463921)
67. Holthe MR, Staff AC, Berge LN, Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. American Journal of Obstetrics and Gynecology 2004;190:1128-1134. (Pubitemid 38561536)
68. Cester N, Staffolani R, Rabini RA, Magnanelli R, Salvolini E, Galassi R, Mazzanti L, Romanini C. Pregnancy induced hypertension: A role for peroxidation in microvillus plasma membranes. Molecular and Cellular Biochemistry 1994;131:151-155. (Pubitemid 24136037)
69. Papageorghiou AT, Yu CK, Erasmus IE, Cuckle HS, Nicolaides KH. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG 2005;112:703-9. (Pubitemid 40852835)
70. Teran E, Escudero C, Vivero S, Calle A, Molina G. NO in early pregnancy and development of preeclampsia. Hypertension 2006;47:17.
71. Teran E, Escudero C, Vivero S, Enriquez A, Calle A. Intraplatelet cyclic guanosine-30,50-monophosphate levels during pregnancy and preeclampsia. Hypertension and Pregnancy 2004;23:303-8. (Pubitemid 39552303)
72. Khan F, Belch JJ, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 2005;46:1123-8. (Pubitemid 41533014)
73. Myatt L. Placental adaptive responses and fetal programming. Journal of Physiology 2006;572:25-30.
74. Von Versen-Hoeynck FM, Powers RW. Maternal-fetal metabolism in normal pregnancy and preeclampsia. Frontiers in Bioscience 2007;12:2457-70.
75. Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental development during the first trimester: Implications for the pathophysiology of pre-eclampsia. Placenta 2000;21:S25-S30.